Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

INOVIO Plans To Submit BLA For INO-3107 In H2

Por: RTTNews Health January 03, 2024

thumbnail

INOVIO () announced plans to submit a BLA for INO-3107 as a potential treatment for Recurrent Respiratory Papillomatosis in the second half of 2024. This followed an Initial Comprehensive Multidisciplinary Breakthrough Therapy Meeting with the FDA on critical aspects of the data package required to submit a BLA under the accelerated approval program.Jacqueline Shea, INOVIO's CEO said: Our plan is to complete the submission of our BLA in the... + full article



Similar News

Inovio Pharma Receives FDA Feedback On Submission Of BLA For INO-3107 To Treat RRP

RTTNews USA Health October 10, 2023

thumbnailBiotechnology company Inovio Pharmaceuticals, Inc. () announced Tuesday that it has received feedback from the U.S. Food and Drug Administration (FDA) that data from its completed Phase 1/2 trial of INO-3107 for the treatment of RRP could support INOVIO's submission of a... + más

INOVIO Says FDA Grants Breakthrough Therapy Designation For INO-3107; Stock Up 15% | RTTNews

INOVIO Reports Positive Interim Phase 1/2 Trial Results For INO-3107 For Respiratory Papillomatosis | RTTNews


INOVIO Says FDA Grants Breakthrough Therapy Designation For INO-3107; Stock Up 15%

RTTNews USA Health September 07, 2023

thumbnailBiotechnology company Inovio Pharmaceuticals, Inc. () announced Thursday that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for INO-3107 as a potential treatment for patients with Recurrent Respiratory Papillomatosis (RRP).The... + más

Inovio Pharma Receives FDA Feedback On Submission Of BLA For INO-3107 To Treat RRP | RTTNews

INOVIO Reports Positive Interim Phase 1/2 Trial Results For INO-3107 For Respiratory Papillomatosis | RTTNews


High school scores and top performers from Tuesday, March 28

Orlando Sentinel USA Sports March 29, 2023

thumbnailLake Brantley 9, Seminole 6 (8 inn.) Buzz: Jackson Golden went 2-for-5 with 2 home runs and 6 RBI for Lake Brantley. Ben Colley had a home run. Bryce Carter had 2 hits for Seminole. Mount Dora Christian Academy 10, Oak Hall (Gainesville) 4 Buzz: Collin Priest went 5-for-5 with a... + más

NFL Playoff Scenarios | ABC News

Le Krewe du Roi celebrates the state at 58th annual Mardi Gras Ball | The Advocate


High school scores and top performers from Friday, March 24

Orlando Sentinel USA Sports March 25, 2023

thumbnailOrangewood Christian 11, The Master’s Academy 1 Buzz: Austin Waring threw 5 innings of 1-run ball (0 earned runs) while allowing 4 hits and striking out 8 for Orangewood Christian. He lowered his season ERA to 0.78. Aiden McKee went 3-for-3 with a double, a walk, an RBI and a... + más

NFL Playoff Scenarios | ABC News

Le Krewe du Roi celebrates the state at 58th annual Mardi Gras Ball | The Advocate


High school scores and top performers from Tuesday, March 7

Orlando Sentinel USA Sports March 08, 2023

thumbnailThe Master’s Academy 12, Lake Highland Prep 0 Buzz: Jackson Bellhorn pitched a complete game with 8 strikeouts for Master’s. Colby Cason went 1-for-2 with 2 RBI, Trey Seluk went 1-for-3 with a double and 2 RBI. Joey Talbot pitched 3 innings striking out 4 for the... + más

NFL Playoff Scenarios | ABC News

Le Krewe du Roi celebrates the state at 58th annual Mardi Gras Ball | The Advocate


INOVIO Pharma Announces Positive Results From Phase 1b Clinical Trial Evaluating INO-4201

RTTNews USA Health February 02, 2023

thumbnailBiotechnology company INOVIO Pharmaceuticals, Inc. () announced Thursday positive results from a Phase 1b clinical trial evaluating INO-4201, a DNA vaccine candidate, as a booster in healthy adult participants who previously received a single injection of Ervebo.In the trial,... + más

INOVIO Reports Positive Interim Phase 1/2 Trial Results For INO-3107 For Respiratory Papillomatosis | RTTNews

Eye drops recalled after 55 reports of bacterial infection, 1 death in 12 states | ABC News


INOVIO Reports Positive Interim Phase 1/2 Trial Results For INO-3107 For Respiratory Papillomatosis

RTTNews USA Health October 13, 2022

thumbnailBiotechnology company Inovio Pharmaceuticals Inc. () announced Thursday positive interim results from an ongoing Phase 1/2 clinical trial evaluating INO-3107 for the treatment of HPV 6 and HPV 11-associated Recurrent Respiratory Papillomatosis (RRP) in adults.In the first cohort... + más

Surge of respiratory illnesses in children straining some hospitals' capacity | ABC News

NKorea launches 2 missiles toward sea after US-SKorea drills | ABC News



About iurex | Privacy Policy | Disclaimer |